Prevention of atrial fibrillation onset by beta-blocker treatment in heart failure: a meta-analysis

Abstract

Aims Atrial fibrillation (AF) is an important morbidity–mortality risk factor, especially in patients with heart failure (HF). Beta-blockers reduce morbidity and mortality in HF. The study was designed to estimate the preventive efficacy of beta-blocker treatment on AF occurrence in patients with HF.